
JFL Life Sciences Ltd Plunges to Lower Circuit Amid Heavy Selling Pressure
2026-01-06 11:00:14JFL Life Sciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 6 Jan 2026 as it hit its lower circuit limit, closing at ₹11.75, down 4.86% from the previous close. The stock’s plunge reflects intense selling pressure and a marked deterioration in investor sentiment, underscored by a significant drop in trading volumes and unfilled supply on the order books.
Read full news article
JFL Life Sciences Ltd Plunges to Lower Circuit Amid Heavy Selling Pressure
2026-01-05 15:00:11Shares of JFL Life Sciences Ltd plunged to their lower circuit limit on 5 Jan 2026, closing at ₹12.35 after a sharp 5.0% decline. The stock witnessed intense selling pressure, with volumes drying up and panic selling dominating trade, signalling heightened investor concern amid a deteriorating outlook for the micro-cap pharmaceutical company.
Read full news article
JFL Life Sciences Ltd Hits Lower Circuit Amid Heavy Selling Pressure
2025-12-31 10:00:24JFL Life Sciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed intense selling pressure on 31 Dec 2025, hitting its lower circuit limit. The stock closed at ₹12.50, marking a maximum daily loss of 3.73%, significantly underperforming the sector and broader market indices. This sharp decline reflects mounting investor concerns amid falling participation and unfilled supply, signalling a potential shift in market sentiment towards the company.
Read full news article
JFL Life Sciences Ltd Plunges to Lower Circuit Amid Heavy Selling Pressure
2025-12-29 13:00:10Shares of JFL Life Sciences Ltd plunged to their lower circuit limit on 29 Dec 2025, reflecting intense selling pressure and a sharp decline of 4.89% in a single trading session. The stock closed at ₹12.65, marking its maximum permissible daily loss and signalling panic selling among investors amid subdued market participation and unfilled supply.
Read full news article
JFL Life Sciences Ltd is Rated Sell
2025-12-26 15:13:38JFL Life Sciences Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 December 2025, providing investors with an up-to-date view of the company's standing in the Pharmaceuticals & Biotechnology sector.
Read full news article
JFL Life Sciences Hits Lower Circuit Amid Heavy Selling Pressure
2025-12-26 11:00:16Shares of JFL Life Sciences Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, faced intense selling pressure on 26 Dec 2025, hitting the lower circuit price limit of ₹13.30. The stock recorded its maximum permissible daily loss of 5.0%, reflecting a sharp decline amid unfilled supply and panic selling, significantly underperforming both its sector and the broader market indices.
Read full news article
JFL Life Sciences Hits Upper Circuit Amid Strong Buying Pressure
2025-12-24 10:00:42JFL Life Sciences Ltd witnessed robust buying interest on 24 Dec 2025, hitting its upper circuit limit with a maximum daily gain of 4.76%. The stock closed at ₹15.40, marking a significant outperformance against its sector and broader market indices, driven by heightened investor participation and unfilled demand.
Read full news article
JFL Life Sciences Hits Upper Circuit Amid Strong Buying Pressure
2025-12-23 11:00:14JFL Life Sciences Ltd witnessed a significant surge in trading activity on 23 Dec 2025, hitting its upper circuit price limit of ₹14.70, marking a maximum daily gain of 5.0%. This movement reflects robust buying interest in the stock within the Pharmaceuticals & Biotechnology sector, accompanied by a regulatory freeze on further transactions, resulting in unfilled demand and heightened market attention.
Read full news article
JFL Life Sciences Hits Upper Circuit Amid Strong Buying Pressure
2025-12-22 10:00:40Shares of JFL Life Sciences Ltd surged to their upper circuit limit on 22 Dec 2025, reflecting robust buying interest and a maximum permissible daily gain of 5%. The stock outperformed its Pharmaceuticals & Biotechnology sector peers and broader market indices, signalling heightened investor enthusiasm despite a micro-cap market capitalisation of ₹45.86 crore.
Read full news articleCorporate Actions
No Upcoming Board Meetings
JFL Life Sciences Ltd has declared 2% dividend, ex-date: 13 Sep 24
No Splits history available
JFL Life Sciences Ltd has announced 2:1 bonus issue, ex-date: 24 Sep 24
No Rights history available






